{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:58Z","timestamp":1792783438403,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["42376089"],"award-info":[{"award-number":["42376089"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fujian Ocean and Fisheries Bureau","award":["FJHYF-L-2025-13"],"award-info":[{"award-number":["FJHYF-L-2025-13"]}]},{"name":"Fujian Province Industry-Academia Collaboration Project","award":["2025N5001"],"award-info":[{"award-number":["2025N5001"]}]},{"name":"Xiamen Ocean Development Bureau","award":["22CZP002HJ08"],"award-info":[{"award-number":["22CZP002HJ08"]}]},{"name":"Pingtan Research Institute of Xiamen University","award":["Z20220743"],"award-info":[{"award-number":["Z20220743"]}],"id":[{"id":"https:\/\/ror.org\/00mcjh785","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"DOI":"10.1007\/s12602-026-11247-9","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:30:13Z","timestamp":1791667813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Novel Cationic Antimicrobial Peptide Scymidgutin8\u221229 from Scylla paramamosain with Antimicrobial and Anti-inflammatory Activities and Therapeutic Potential in DSS-induced Colitis in Mice"],"prefix":"10.1007","author":[{"given":"Chang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianxian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5714-1339","authenticated-orcid":false,"given":"Fangyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"key":"11247_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor B, Gardet A, Xavier RJ (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature 474:307\u2013317. https:\/\/doi.org\/10.1038\/nature10209","journal-title":"Nature"},{"key":"11247_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","volume":"13","author":"HS de Souza","year":"2016","unstructured":"de Souza HS, Fiocchi C (2016) Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol 13:13\u201327. https:\/\/doi.org\/10.1038\/nrgastro.2015.186","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11247_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2013.240","volume":"11","author":"J Ruel","year":"2014","unstructured":"Ruel J, Ruane D, Mehandru S et al (2014) IBD across the age spectrum: is it the same disease? Nat Rev Gastroenterol Hepatol 11:88\u201398. https:\/\/doi.org\/10.1038\/nrgastro.2013.240","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11247_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","volume":"14","author":"J Ni","year":"2017","unstructured":"Ni J, Wu GD, Albenberg L, Tomov VT (2017) Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol 14:573\u2013584. https:\/\/doi.org\/10.1038\/nrgastro.2017.88","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11247_CR5","doi-asserted-by":"publisher","first-page":"14000","DOI":"10.1073\/pnas.1510084112","volume":"112","author":"LF Courth","year":"2015","unstructured":"Courth LF, Ostaff MJ, Mail\u00e4nder-S\u00e1nchez D et al (2015) Crohn\u2018s disease-derived monocytes fail to induce Paneth cell defensins. Proc Natl Acad Sci U S A 112:14000\u201314005. https:\/\/doi.org\/10.1073\/pnas.1510084112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11247_CR6","doi-asserted-by":"publisher","first-page":"18129","DOI":"10.1073\/pnas.0505256102","volume":"102","author":"J Wehkamp","year":"2005","unstructured":"Wehkamp J, Salzman NH, Porter E et al (2005) Reduced Paneth cell alpha-defensins in ileal Crohn\u2019s disease. Proc Natl Acad Sci U S A 102:18129\u201318134. https:\/\/doi.org\/10.1073\/pnas.0505256102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11247_CR7","doi-asserted-by":"publisher","first-page":"5499","DOI":"10.3748\/wjg.14.5499","volume":"14","author":"M Gersemann","year":"2008","unstructured":"Gersemann M, Wehkamp J, Fellermann K, Stange EF (2008) Crohn\u2018s disease\u2014defect in innate defence. World J Gastroenterol 14:5499\u20135503. https:\/\/doi.org\/10.3748\/wjg.14.5499","journal-title":"World J Gastroenterol"},{"key":"11247_CR8","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1136\/gutjnl-2017-314903","volume":"67","author":"C Palmela","year":"2018","unstructured":"Palmela C, Chevarin C, Xu Z et al (2018) Adherent-invasive Escherichia coli in inflammatory bowel disease. Gut 67:574\u2013587. https:\/\/doi.org\/10.1136\/gutjnl-2017-314903","journal-title":"Gut"},{"key":"11247_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuad039","volume":"47","author":"R Mart\u00edn","year":"2023","unstructured":"Mart\u00edn R, Rios-Covian D, Huillet E et al (2023) Faecalibacterium: a bacterial genus with promising human health applications. FEMS Microbiol Rev 47:fuad039. https:\/\/doi.org\/10.1093\/femsre\/fuad039","journal-title":"FEMS Microbiol Rev"},{"key":"11247_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/gutjnl-2014-307649","volume":"65","author":"E Qu\u00e9vrain","year":"2016","unstructured":"Qu\u00e9vrain E, Maubert MA, Michon C et al (2016) Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn\u2018s disease. Gut 65:415\u2013425. https:\/\/doi.org\/10.1136\/gutjnl-2014-307649","journal-title":"Gut"},{"key":"11247_CR11","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","volume":"63","author":"K Machiels","year":"2014","unstructured":"Machiels K, Joossens M, Sabino J et al (2014) A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63:1275\u20131283. https:\/\/doi.org\/10.1136\/gutjnl-2013-304833","journal-title":"Gut"},{"key":"11247_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S2468-1253(21)00223-5","volume":"7","author":"K Papamichael","year":"2022","unstructured":"Papamichael K, Afif W, Drobne D et al (2022) Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives. Lancet Gastroenterol Hepatol 7:171\u2013185. https:\/\/doi.org\/10.1016\/S2468-1253(21)00223-5","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"11247_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1424606","volume":"15","author":"Z Zeng","year":"2024","unstructured":"Zeng Z, Lin H, Jiang M et al (2024) Anti-TNF\u03b1 in inflammatory bowel disease: from originators to biosimilars. Front Pharmacol 15:1424606. https:\/\/doi.org\/10.3389\/fphar.2024.1424606","journal-title":"Front Pharmacol"},{"key":"11247_CR14","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/S0140-6736(18)32592-3","volume":"393","author":"JS Hyams","year":"2019","unstructured":"Hyams JS, Davis Thomas S, Gotman N et al (2019) Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study. Lancet 393:1708\u20131720. https:\/\/doi.org\/10.1016\/S0140-6736(18)32592-3","journal-title":"Lancet"},{"key":"11247_CR15","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/ibd\/izad138","volume":"30","author":"B Bokemeyer","year":"2024","unstructured":"Bokemeyer B, Plachta-Danielzik S, di Giuseppe R et al (2024) Real-world effectiveness of vedolizumab vs anti-TNF in biologic-naive Crohn\u2019s disease patients: a 2-year propensity-score-adjusted analysis from the VEDOIBD-study. Inflamm Bowel Dis 30:746\u2013756. https:\/\/doi.org\/10.1093\/ibd\/izad138","journal-title":"Inflamm Bowel Dis"},{"key":"11247_CR16","doi-asserted-by":"publisher","first-page":"7402","DOI":"10.3748\/wjg.v27.i43.7402","volume":"27","author":"J Gubatan","year":"2021","unstructured":"Gubatan J, Holman DR, Puntasecca CJ et al (2021) Antimicrobial peptides and the gut microbiome in inflammatory bowel disease. World J Gastroenterol 27:7402\u20137422. https:\/\/doi.org\/10.3748\/wjg.v27.i43.7402","journal-title":"World J Gastroenterol"},{"key":"11247_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nri.2016.29","volume":"16","author":"REW Hancock","year":"2016","unstructured":"Hancock REW, Haney EF, Gill EE (2016) The immunology of host defence peptides: beyond antimicrobial activity. Nat Rev Immunol 16:321\u2013334. https:\/\/doi.org\/10.1038\/nri.2016.29","journal-title":"Nat Rev Immunol"},{"key":"11247_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50223-1","volume":"15","author":"J Sun","year":"2024","unstructured":"Sun J, Chen M, Hu Z et al (2024) Ribonuclease 4 functions as an intestinal antimicrobial protein to maintain gut microbiota and metabolite homeostasis. Nat Commun 15:5778. https:\/\/doi.org\/10.1038\/s41467-024-50223-1","journal-title":"Nat Commun"},{"key":"11247_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","volume":"19","author":"N Mookherjee","year":"2020","unstructured":"Mookherjee N, Anderson MA, Haagsman HP, Davidson DJ (2020) Antimicrobial host defence peptides: functions and clinical potential. Nat Rev Drug Discov 19:311\u2013332. https:\/\/doi.org\/10.1038\/s41573-019-0058-8","journal-title":"Nat Rev Drug Discov"},{"key":"11247_CR20","doi-asserted-by":"publisher","first-page":"11567","DOI":"10.1038\/ncomms11567","volume":"7","author":"MJA van der Plas","year":"2016","unstructured":"van der Plas MJA, Bhongir RKV, Kjellstr\u00f6m S et al (2016) Pseudomonas aeruginosa elastase cleaves a C-terminal peptide from human thrombin that inhibits host inflammatory responses. Nat Commun 7:11567. https:\/\/doi.org\/10.1038\/ncomms11567","journal-title":"Nat Commun"},{"key":"11247_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00646","volume":"11","author":"J Wehkamp","year":"2020","unstructured":"Wehkamp J, Stange EF (2020) An update review on the Paneth cell as key to ileal Crohn\u2018s disease. Front Immunol 11:646. https:\/\/doi.org\/10.3389\/fimmu.2020.00646","journal-title":"Front Immunol"},{"key":"11247_CR22","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrmicro2546","volume":"9","author":"CL Bevins","year":"2011","unstructured":"Bevins CL, Salzman NH (2011) Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol 9:356\u2013368. https:\/\/doi.org\/10.1038\/nrmicro2546","journal-title":"Nat Rev Microbiol"},{"key":"11247_CR23","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/emmm.201201773","volume":"5","author":"MJ Ostaff","year":"2013","unstructured":"Ostaff MJ, Stange EF, Wehkamp J (2013) Antimicrobial peptides and gut microbiota in homeostasis and pathology. EMBO Mol Med 5:1465\u20131483. https:\/\/doi.org\/10.1002\/emmm.201201773","journal-title":"EMBO Mol Med"},{"key":"11247_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/1749-4877.70134","author":"Y Peng","year":"2026","unstructured":"Peng Y, Wu Y, Fu Z et al (2026) Amphibian-derived peptide OA-AL14 alleviates UVB-induced skin photoaging via autophagy activation mediated by the AMPK\/mTOR pathway. Integr Zool. https:\/\/doi.org\/10.1111\/1749-4877.70134","journal-title":"Integr Zool"},{"key":"11247_CR25","doi-asserted-by":"publisher","first-page":"727","DOI":"10.24272\/j.issn.2095-8137.2026.076","volume":"47","author":"CJ Deng","year":"2026","unstructured":"Deng CJ, Wang Y, Yang XW (2026) Amphibian-derived peptides as novel therapeutics for skin wound healing: mechanisms, applications, and challenges. Zool Res 47:727\u2013747. https:\/\/doi.org\/10.24272\/j.issn.2095-8137.2026.076","journal-title":"Zool Res"},{"key":"11247_CR26","doi-asserted-by":"publisher","first-page":"748","DOI":"10.24272\/j.issn.2095-8137.2025.499","volume":"47","author":"X Liu","year":"2026","unstructured":"Liu X, Liu J, Li B et al (2026) First identification of an amphibian-derived peptide with anti-vascular aging activity. Zool Res 47:748\u2013764. https:\/\/doi.org\/10.24272\/j.issn.2095-8137.2025.499","journal-title":"Zool Res"},{"key":"11247_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-026-10766-z","author":"Z Fu","year":"2026","unstructured":"Fu Z, Xiao Z, Li Y et al (2026) A frog bioactive peptide suppresses inflammation by modulating autophagy for skin wound regeneration. Commun Biol. https:\/\/doi.org\/10.1038\/s42003-026-10766-z","journal-title":"Commun Biol"},{"key":"11247_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2026.173231","volume":"530","author":"Z Fu","year":"2026","unstructured":"Fu Z, Jiang J, Jia Q et al (2026) The self-assembling amphibian-derived peptide (RADA)4-FZ1 pioneers a novel therapeutic platform for diabetic skin wound management. Chem Eng J 530:173231. https:\/\/doi.org\/10.1016\/j.cej.2026.173231","journal-title":"Chem Eng J"},{"key":"11247_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41536-026-00487-6","author":"J Wang","year":"2026","unstructured":"Wang J, Yang Y, Ru Z et al (2026) Food-derived peptide RDP3 mitigates pyroptosis to enhance oral mucosal repair via the IL-2R\u03b2\/PI3K axis. NPJ Regen Med. https:\/\/doi.org\/10.1038\/s41536-026-00487-6","journal-title":"NPJ Regen Med"},{"key":"11247_CR30","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.fsi.2019.07.076","volume":"93","author":"F Chen","year":"2019","unstructured":"Chen F, Wang K (2019) Characterization of the innate immunity in the mud crab Scylla paramamosain. Fish Shellfish Immunol 93:436\u2013448. https:\/\/doi.org\/10.1016\/j.fsi.2019.07.076","journal-title":"Fish Shellfish Immunol"},{"key":"11247_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.aquaculture.2024.741137","volume":"591","author":"C Zhang","year":"2024","unstructured":"Zhang C, Chen F, Bai Y et al (2024) A novel antimicrobial peptide Spasin141-165 identified from Scylla paramamosain exhibiting protection against Aeromonas hydrophila infection. Aquaculture 591:741137. https:\/\/doi.org\/10.1016\/j.aquaculture.2024.741137","journal-title":"Aquaculture"},{"key":"11247_CR32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.biotechadv.2011.05.021","volume":"29","author":"SV Sperstad","year":"2011","unstructured":"Sperstad SV, Haug T, Blencke HM et al (2011) Antimicrobial peptides from marine invertebrates: challenges and perspectives in marine antimicrobial peptide discovery. Biotechnol Adv 29:519\u2013530. https:\/\/doi.org\/10.1016\/j.biotechadv.2011.05.021","journal-title":"Biotechnol Adv"},{"key":"11247_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.dci.2017.05.009","volume":"80","author":"A Tassanakajon","year":"2018","unstructured":"Tassanakajon A, Rimphanitchayakit V, Visetnan S et al (2018) Shrimp humoral responses against pathogens: antimicrobial peptides and melanization. Dev Comp Immunol 80:81\u201393. https:\/\/doi.org\/10.1016\/j.dci.2017.05.009","journal-title":"Dev Comp Immunol"},{"key":"11247_CR34","unstructured":"Wang K, Zhang C, Chen F, Hao H (2024) An antimicrobial peptide Scymidgutin from Scylla paramamosain and its applications. Chinese Patent Application, Publication No. CN117567581A"},{"key":"11247_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118078","volume":"299","author":"Y He","year":"2025","unstructured":"He Y, Li M, Su J et al (2025) Expanding the antimicrobial spectrum of lugdunin: discovery of multi-cationic derivatives of lugdunin with antimicrobial activity against gram-positive and gram-negative bacteria. Eur J Med Chem 299:118078. https:\/\/doi.org\/10.1016\/j.ejmech.2025.118078","journal-title":"Eur J Med Chem"},{"key":"11247_CR36","doi-asserted-by":"publisher","first-page":"536","DOI":"10.4062\/biomolther.2020.227","volume":"29","author":"HD Jhundoo","year":"2021","unstructured":"Jhundoo HD, Siefen T, Liang A et al (2021) Hyaluronic acid increases anti-inflammatory efficacy of rectal 5-amino salicylic acid administration in a murine colitis model. Biomol Ther 29:536\u2013544. https:\/\/doi.org\/10.4062\/biomolther.2020.227","journal-title":"Biomol Ther"},{"key":"11247_CR37","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.adk7633","volume":"388","author":"WJ Ma","year":"2025","unstructured":"Ma WJ, Wang C, Kothandapani J et al (2025) Bespoke plant glycoconjugates for gut microbiota-mediated drug targeting. Science 388:1410\u20131416. https:\/\/doi.org\/10.1126\/science.adk7633","journal-title":"Science"},{"key":"11247_CR38","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1126\/science.1260580","volume":"347","author":"TW Cullen","year":"2015","unstructured":"Cullen TW, Schofield WB, Barry NA et al (2015) Antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation. Science 347:170\u2013175. https:\/\/doi.org\/10.1126\/science.1260580","journal-title":"Science"},{"key":"11247_CR39","doi-asserted-by":"publisher","first-page":"20150300","DOI":"10.1098\/rstb.2015.0300","volume":"371","author":"D Destoumieux-Garz\u00f3n","year":"2016","unstructured":"Destoumieux-Garz\u00f3n D, Rosa RD, Schmitt P et al (2016) Antimicrobial peptides in marine invertebrate health and disease. Philos Trans R Soc Lond B Biol Sci 371:20150300. https:\/\/doi.org\/10.1098\/rstb.2015.0300","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"11247_CR40","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrmicro1098","volume":"3","author":"KA Brogden","year":"2005","unstructured":"Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238\u2013250. https:\/\/doi.org\/10.1038\/nrmicro1098","journal-title":"Nat Rev Microbiol"},{"key":"11247_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/MOH.0b013e32831ac517","volume":"16","author":"A Nijnik","year":"2009","unstructured":"Nijnik A, Hancock REW (2009) The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol 16:41\u201347. https:\/\/doi.org\/10.1097\/MOH.0b013e32831ac517","journal-title":"Curr Opin Hematol"},{"key":"11247_CR42","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/biom14030320","volume":"14","author":"S Bhattacharjya","year":"2024","unstructured":"Bhattacharjya S, Zhang Z, Ramamoorthy A (2024) LL-37: structures, antimicrobial activity, and influence on amyloid-related diseases. Biomolecules 14:320. https:\/\/doi.org\/10.3390\/biom14030320","journal-title":"Biomolecules"},{"key":"11247_CR43","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1021\/acsbiomaterials.4c02029","volume":"11","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Li J, Wei G et al (2025) Exploring the antimicrobial potential of LL-37 derivatives: recent developments and challenges. ACS Biomater Sci Eng 11:3145\u20133164. https:\/\/doi.org\/10.1021\/acsbiomaterials.4c02029","journal-title":"ACS Biomater Sci Eng"},{"key":"11247_CR44","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A, Mohammadian S, Vazini H et al (2018) Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol 233:6425\u20136440. https:\/\/doi.org\/10.1002\/jcp.26429","journal-title":"J Cell Physiol"},{"key":"11247_CR45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen JE, Biswas SK et al (2014) Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41:14\u201320. https:\/\/doi.org\/10.1016\/j.immuni.2014.06.008","journal-title":"Immunity"},{"key":"11247_CR46","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.bbamem.2008.09.013","volume":"1788","author":"K Matsuzaki","year":"2009","unstructured":"Matsuzaki K (2009) Control of cell selectivity of antimicrobial peptides. Biochim Biophys Acta 1788:1687\u20131692. https:\/\/doi.org\/10.1016\/j.bbamem.2008.09.013","journal-title":"Biochim Biophys Acta"},{"key":"11247_CR47","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature06005","volume":"448","author":"RJ Xavier","year":"2007","unstructured":"Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427\u2013434. https:\/\/doi.org\/10.1038\/nature06005","journal-title":"Nature"},{"key":"11247_CR48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1749-6632.2011.06339.x","volume":"1246","author":"EO Glocker","year":"2011","unstructured":"Glocker EO, Kotlarz D, Klein C et al (2011) IL-10 and IL-10 receptor defects in humans. Ann N Y Acad Sci 1246:102\u2013107. https:\/\/doi.org\/10.1111\/j.1749-6632.2011.06339.x","journal-title":"Ann N Y Acad Sci"},{"key":"11247_CR49","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price J, Arze C, Ananthakrishnan AN et al (2019) Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569:655\u2013662. https:\/\/doi.org\/10.1038\/s41586-019-1237-9","journal-title":"Nature"},{"key":"11247_CR50","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1126\/science.1223813","volume":"336","author":"JK Nicholson","year":"2012","unstructured":"Nicholson JK, Holmes E, Kinross J et al (2012) Host-gut microbiota metabolic interactions. Science 336:1262\u20131267. https:\/\/doi.org\/10.1126\/science.1223813","journal-title":"Science"},{"key":"11247_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1395861","volume":"11","author":"EF Stange","year":"2024","unstructured":"Stange EF (2024) Dysbiosis in inflammatory bowel diseases: egg, not chicken. Front Med 11:1395861. https:\/\/doi.org\/10.3389\/fmed.2024.1395861","journal-title":"Front Med"},{"key":"11247_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34263-4","volume":"8","author":"PK Shukla","year":"2018","unstructured":"Shukla PK, Meena AS, Rao V et al (2018) Human defensin-5 blocks ethanol and colitis-induced dysbiosis, tight junction disruption and inflammation in mouse intestine. Sci Rep 8:16241. https:\/\/doi.org\/10.1038\/s41598-018-34263-4","journal-title":"Sci Rep"},{"key":"11247_CR53","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E (2020) Interaction between microbiota and immunity in health and disease. Cell Res 30:492\u2013506. https:\/\/doi.org\/10.1038\/s41422-020-0332-7","journal-title":"Cell Res"},{"key":"11247_CR54","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.4049\/jimmunol.1402300","volume":"194","author":"F Han","year":"2015","unstructured":"Han F, Zhang H, Xia X et al (2015) Porcine \u03b2-defensin 2 attenuates inflammation and mucosal lesions in dextran sodium sulfate-induced colitis. J Immunol 194:1882\u20131893. https:\/\/doi.org\/10.4049\/jimmunol.1402300","journal-title":"J Immunol"},{"key":"11247_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813878","volume":"24","author":"LF Rosa","year":"2023","unstructured":"Rosa LF, Rings A, Stolzer I et al (2023) Human \u03b1-defensin 51\u20139 and human \u03b2-defensin 2 improve metabolic parameters and gut barrier function in mice fed a Western-style diet. Int J Mol Sci 24:13878. https:\/\/doi.org\/10.3390\/ijms241813878","journal-title":"Int J Mol Sci"},{"key":"11247_CR56","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.3390\/nu14142864","volume":"14","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Guo C, Li Y et al (2022) Alginate oligosaccharides ameliorate DSS-induced colitis through modulation of AMPK\/NF-\u03baB pathway and intestinal microbiota. Nutrients 14:2864. https:\/\/doi.org\/10.3390\/nu14142864","journal-title":"Nutrients"},{"key":"11247_CR57","doi-asserted-by":"publisher","first-page":"13780","DOI":"10.1073\/pnas.0706625104","volume":"104","author":"DN Frank","year":"2007","unstructured":"Frank DN, St Amand AL, Feldman RA et al (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104:13780\u201313785. https:\/\/doi.org\/10.1073\/pnas.0706625104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11247_CR58","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.chom.2015.09.002","volume":"18","author":"KA Earle","year":"2015","unstructured":"Earle KA, Billings G, Sigal M et al (2015) Quantitative imaging of gut microbiota spatial organization. Cell Host Microbe 18:478\u2013488. https:\/\/doi.org\/10.1016\/j.chom.2015.09.002","journal-title":"Cell Host Microbe"},{"key":"11247_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00281","volume":"8","author":"M Lopez-Siles","year":"2018","unstructured":"Lopez-Siles M, Enrich-Cap\u00f3 N, Aldeguer X et al (2018) Alterations in the abundance and co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the colonic mucosa of inflammatory bowel disease subjects. Front Cell Infect Microbiol 8:281. https:\/\/doi.org\/10.3389\/fcimb.2018.00281","journal-title":"Front Cell Infect Microbiol"},{"key":"11247_CR60","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/mi.2016.75","volume":"10","author":"MY Zeng","year":"2017","unstructured":"Zeng MY, Inohara N, Nu\u00f1ez G (2017) Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol 10:18\u201326. https:\/\/doi.org\/10.1038\/mi.2016.75","journal-title":"Mucosal Immunol"},{"key":"11247_CR61","doi-asserted-by":"publisher","first-page":"15.25.1","DOI":"10.1002\/0471142735.im1525s104","volume":"104","author":"B Chassaing","year":"2014","unstructured":"Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M (2014) Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol 104:15.25.1-15.25.14. https:\/\/doi.org\/10.1002\/0471142735.im1525s104","journal-title":"Curr Protoc Immunol"},{"key":"11247_CR62","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nprot.2007.41","volume":"2","author":"S Wirtz","year":"2007","unstructured":"Wirtz S, Neufert C, Weigmann B, Neurath MF (2007) Chemically induced mouse models of intestinal inflammation. Nat Protoc 2:541\u2013546. https:\/\/doi.org\/10.1038\/nprot.2007.41","journal-title":"Nat Protoc"},{"key":"11247_CR63","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri3661","volume":"14","author":"MF Neurath","year":"2014","unstructured":"Neurath MF (2014) Cytokines in inflammatory bowel disease. Nat Rev Immunol 14:329\u2013342. https:\/\/doi.org\/10.1038\/nri3661","journal-title":"Nat Rev Immunol"},{"key":"11247_CR64","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1556\/1886.2016.00036","volume":"6","author":"U Fiebiger","year":"2016","unstructured":"Fiebiger U, Bereswill S, Heimesaat MM (2016) Dissecting the interplay between intestinal microbiota and host immunity in health and disease: lessons learned from germfree and gnotobiotic animal models. Eur J Microbiol Immunol 6:253\u2013271. https:\/\/doi.org\/10.1556\/1886.2016.00036","journal-title":"Eur J Microbiol Immunol"},{"key":"11247_CR65","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3389\/fphys.2018.01534","volume":"9","author":"EA Kennedy","year":"2018","unstructured":"Kennedy EA, King KY, Baldridge MT (2018) Mouse microbiota models: comparing germ-free mice and antibiotics treatment as tools for modifying gut bacteria. Front Physiol 9:1534. https:\/\/doi.org\/10.3389\/fphys.2018.01534","journal-title":"Front Physiol"},{"key":"11247_CR66","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/gast.2002.30294","volume":"122","author":"A Swidsinski","year":"2002","unstructured":"Swidsinski A, Ladhoff A, Pernthaler A et al (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122:44\u201354. https:\/\/doi.org\/10.1053\/gast.2002.30294","journal-title":"Gastroenterology"},{"issue":"Suppl 6","key":"11247_CR67","first-page":"61","volume":"60","author":"A Swidsinski","year":"2009","unstructured":"Swidsinski A, Loening-Baucke V, Herber A (2009) Mucosal flora in Crohn\u2018s disease and ulcerative colitis\u2014an overview. J Physiol Pharmacol 60(Suppl 6):61\u201371","journal-title":"J Physiol Pharmacol"},{"key":"11247_CR68","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/md24020076","volume":"24","author":"Y Lu","year":"2026","unstructured":"Lu Y, Zhang B, Wang Z et al (2026) From host-derived pressures to the environmental anti-antimicrobial peptides resistome: mechanisms, reservoirs and implications for therapeutic peptide design. Mar Drugs 24:76. https:\/\/doi.org\/10.3390\/md24020076","journal-title":"Mar Drugs"},{"key":"11247_CR69","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.1128\/AAC.00440-09","volume":"53","author":"KS Brinch","year":"2009","unstructured":"Brinch KS, Frimodt-M\u00f8ller N, H\u00f8iby N, Kristensen HH (2009) Influence of antidrug antibodies on plectasin efficacy and pharmacokinetics. Antimicrob Agents Chemother 53:4794\u20134800. https:\/\/doi.org\/10.1128\/AAC.00440-09","journal-title":"Antimicrob Agents Chemother"},{"key":"11247_CR70","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/intimm\/12.3.375","volume":"12","author":"B Hemmer","year":"2000","unstructured":"Hemmer B, Kondo T, Gran B et al (2000) Minimal peptide length requirements for CD4+ T cell clones\u2014implications for molecular mimicry and T cell survival. Int Immunol 12:375\u2013383. https:\/\/doi.org\/10.1093\/intimm\/12.3.375","journal-title":"Int Immunol"},{"key":"11247_CR71","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/antib14040106","volume":"14","author":"CH Chen","year":"2025","unstructured":"Chen CH, Chiu YC, Huang KY et al (2025) A reproducible sequence-level strategy to enhance peptide immunogenicity while preserving wild-type epitope recognition. Antibodies 14:106. https:\/\/doi.org\/10.3390\/antib14040106","journal-title":"Antibodies"},{"key":"11247_CR72","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1021\/acsbiomaterials.5c01852","volume":"12","author":"T Dam","year":"2026","unstructured":"Dam T, Sharma P, Kaur P et al (2026) Engineering peptide-based hydrogels: smart therapeutic platforms for inflammatory disorders. ACS Biomater Sci Eng 12:1868\u20131912. https:\/\/doi.org\/10.1021\/acsbiomaterials.5c01852","journal-title":"ACS Biomater Sci Eng"},{"key":"11247_CR73","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/bit.28283","volume":"120","author":"L Colomina-Alfaro","year":"2023","unstructured":"Colomina-Alfaro L, Marchesan S, Stamboulis A, Bandiera A (2023) Smart tools for antimicrobial peptides expression and application: the elastic perspective. Biotechnol Bioeng 120:323\u2013332. https:\/\/doi.org\/10.1002\/bit.28283","journal-title":"Biotechnol Bioeng"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11247-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-026-11247-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11247-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:05:34Z","timestamp":1791673534000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-026-11247-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":73,"alternative-id":["11247"],"URL":"https:\/\/doi.org\/10.1007\/s12602-026-11247-9","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,10]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}